rs3801994

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001753.5(CAV1):​c.196-8531G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0728 in 152,092 control chromosomes in the GnomAD database, including 657 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.073 ( 657 hom., cov: 32)

Consequence

CAV1
NM_001753.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0500

Publications

6 publications found
Variant links:
Genes affected
CAV1 (HGNC:1527): (caveolin 1) The scaffolding protein encoded by this gene is the main component of the caveolae plasma membranes found in most cell types. The protein links integrin subunits to the tyrosine kinase FYN, an initiating step in coupling integrins to the Ras-ERK pathway and promoting cell cycle progression. The gene is a tumor suppressor gene candidate and a negative regulator of the Ras-p42/44 mitogen-activated kinase cascade. Caveolin 1 and caveolin 2 are located next to each other on chromosome 7 and express colocalizing proteins that form a stable hetero-oligomeric complex. Mutations in this gene have been associated with Berardinelli-Seip congenital lipodystrophy. Alternatively spliced transcripts encode alpha and beta isoforms of caveolin 1.[provided by RefSeq, Mar 2010]
CAV1 Gene-Disease associations (from GenCC):
  • pulmonary arterial hypertension
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • partial lipodystrophy, congenital cataracts, and neurodegeneration syndrome
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • pulmonary hypertension, primary, 3
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • congenital generalized lipodystrophy type 3
    Inheritance: AD, AR Classification: MODERATE, LIMITED Submitted by: Ambry Genetics, G2P
  • heritable pulmonary arterial hypertension
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Berardinelli-Seip congenital lipodystrophy
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • amyotrophic lateral sclerosis
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.199 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CAV1NM_001753.5 linkc.196-8531G>A intron_variant Intron 2 of 2 ENST00000341049.7 NP_001744.2 Q03135-1Q2TNI1Q59E85
CAV1NM_001172895.1 linkc.103-8531G>A intron_variant Intron 2 of 2 NP_001166366.1 A0A024R757Q2TNI1Q59E85
CAV1NM_001172896.2 linkc.103-8531G>A intron_variant Intron 1 of 1 NP_001166367.1 A0A024R757Q2TNI1Q7Z4F3Q59E85
CAV1NM_001172897.2 linkc.103-8531G>A intron_variant Intron 2 of 2 NP_001166368.1 A0A024R757Q2TNI1A9XTE5Q59E85

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CAV1ENST00000341049.7 linkc.196-8531G>A intron_variant Intron 2 of 2 1 NM_001753.5 ENSP00000339191.2 Q03135-1

Frequencies

GnomAD3 genomes
AF:
0.0728
AC:
11068
AN:
151974
Hom.:
657
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0177
Gnomad AMI
AF:
0.0439
Gnomad AMR
AF:
0.0831
Gnomad ASJ
AF:
0.0363
Gnomad EAS
AF:
0.210
Gnomad SAS
AF:
0.127
Gnomad FIN
AF:
0.184
Gnomad MID
AF:
0.0316
Gnomad NFE
AF:
0.0756
Gnomad OTH
AF:
0.0569
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0728
AC:
11067
AN:
152092
Hom.:
657
Cov.:
32
AF XY:
0.0789
AC XY:
5863
AN XY:
74314
show subpopulations
African (AFR)
AF:
0.0177
AC:
734
AN:
41530
American (AMR)
AF:
0.0831
AC:
1271
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.0363
AC:
126
AN:
3472
East Asian (EAS)
AF:
0.210
AC:
1082
AN:
5156
South Asian (SAS)
AF:
0.126
AC:
608
AN:
4810
European-Finnish (FIN)
AF:
0.184
AC:
1936
AN:
10540
Middle Eastern (MID)
AF:
0.0340
AC:
10
AN:
294
European-Non Finnish (NFE)
AF:
0.0756
AC:
5141
AN:
67980
Other (OTH)
AF:
0.0563
AC:
119
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
493
985
1478
1970
2463
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
136
272
408
544
680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0648
Hom.:
48
Bravo
AF:
0.0647
Asia WGS
AF:
0.136
AC:
476
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.81
CADD
Benign
4.6
DANN
Benign
0.72
PhyloP100
-0.050
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3801994; hg19: chr7-116190469; API